These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3115453)

  • 21. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
    Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
    Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD; Delgado MR
    Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroperitoneal fibrosis in two patients with Parkinson's disease treated with bromocriptine.
    Kains JP; Hardy JC; Chevalier C; Collier A
    Acta Clin Belg; 1990; 45(5):306-10. PubMed ID: 2177299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple valvular regurgitation associated with bromocriptine therapy.
    Cautres T; Cautres M; Mohty D
    Arch Cardiovasc Dis; 2014 Oct; 107(10):579-80. PubMed ID: 23791579
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
    Anglès A; Bagheri H; Saivin S; Montastruc JL
    Therapie; 2002; 57(4):408-10. PubMed ID: 12422563
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical assessment of therapeutic results of Ergolactyn (bromocriptine) in Parkinson's disease].
    Kuran W; Kulczycki J
    Neurol Neurochir Pol; 1993; 27(4):507-13. PubMed ID: 8247238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
    BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Vogel HP; Schiffter R
    Pharmacopsychiatria; 1983 Jul; 16(4):107-10. PubMed ID: 6685318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine in Parkinsonism.
    Pearce I; Pearce JM
    Br Med J; 1978 May; 1(6124):1402-4. PubMed ID: 348261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine combined with levodopa in Parkinson's disease.
    Gauthier G; Martins da Silva A
    Eur Neurol; 1982; 21(4):217-26. PubMed ID: 7117308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
    Montastruc JL; Rascol O; Senard JM; Rascol A
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1034-8. PubMed ID: 8089666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An ergot derivative in the treatment of Parkinson's disease.
    Calne DB; Shoulson I; Kartzinel R
    Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
    [No Abstract]   [Full Text] [Related]  

  • 35. An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Mackenzie RA; Lance JW
    Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychic side effects of bromocriptine in Parkinson's disease].
    Simonetta M; Schmitt L; Montastruc JL; Rascol A
    Rev Neurol (Paris); 1987; 143(8-9):608-11. PubMed ID: 3671965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 38. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.
    Lancet; 1981 Jan; 1(8210):44-5. PubMed ID: 6109080
    [No Abstract]   [Full Text] [Related]  

  • 39. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E; Viljanen A
    Chest; 1988 Nov; 94(5):1034-6. PubMed ID: 3180854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bromocriptine in Parkinson's disease. Personal experience].
    Chacón JR; Piqueras L; Pery JM
    Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.